Favivir 800/200 will be available in a pack containing 16 tablets of favipiravir 800 mg and 2 tablets of favipiravir 200 mg priced at Rs 2,640 per pack, Hetero said in a statement.
Favivir improves treatment accessibility to a significant amount of COVID-19 patient population, which usually sustains mild to moderate symptoms.
Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease.
Following the approval of Covifor, the generic version of Remdesivir, by the Drug Controller General of India (DCGI), Hetero Healthcare Limited is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each.
With pharmaceutical companies launching generic versions of Remdesivir and Favipiravir for COVID-19 treatment, medical experts on Monday said it was a "positive development" in the fight against the pandemic, but cautioned against regarding the antiviral drugs as "game changers".
Drug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19.
Hyderabad: City-based Hetero Healthcare Limited, the first pharma company in India to launch anti-H1N1 drug Oseltamivir in retail market, today said it has increased its Fluvir production by 400 per cent to address the present
Top News
Latest News
